Francesco Tovoli (F Tovoli)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 60

Top Venues

Cancers

Liver international : official journal of the International Association for the Study of the Liver

Current oncology (Toronto, Ont.)

Expert review of anticancer therapy

University of Bologna

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bologna

Italy

Assistant Professor :: Medical and Surgical Sciences

Publications

Dante Pio Pallotta, Alessandro Granito, Alberto Raiteri, Maria Boe, Agnese Pratelli, Alice Giamperoli, Giovanni Monaco, Chiara Faggiano, Francesco Tovoli
Autoimmune Polyendocrine Syndromes in Adult Italian Celiac Disease Patients. Journal of clinical medicine 13 (2) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Federico Monti, Federica Perazza, Laura Leoni, Bernardo Stefanini, Silvia Ferri, Francesco Tovoli, Guido Zavatta, Piscaglia Fabio, Maria Letizia Petroni, Federico Ravaioli
RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives. International journal of molecular sciences 25 (17) (2024)
Luca Ielasi, Bernardo Stefanini, Fabio Conti, Matteo Tonnini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Francesco Giuseppe Foschi, Piscaglia Fabio, Alessandro Granito, Francesco Tovoli
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy. Current oncology (Toronto, Ont.) 31 (1) (2024)
Luca Ielasi, Bernardo Stefanini, Fabio Conti, Matteo Tonnini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Francesco Giuseppe Foschi, Piscaglia Fabio, Alessandro Granito, Francesco Tovoli
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy. Current oncology (Toronto, Ont.) 31 (1) (2024)
Luca Ielasi, Bernardo Stefanini, Fabio Conti, Matteo Tonnini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Francesco Giuseppe Foschi, Piscaglia Fabio, Alessandro Granito, Francesco Tovoli
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy. Current oncology (Toronto, Ont.) 31 (1) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver (2024)
Dante Pio Pallotta, Alessandro Granito, Alberto Raiteri, Maria Boe, Agnese Pratelli, Alice Giamperoli, Giovanni Monaco, Chiara Faggiano, Francesco Tovoli
Autoimmune Polyendocrine Syndromes in Adult Italian Celiac Disease Patients. Journal of clinical medicine 13 (2) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Luca Ielasi, Bernardo Stefanini, Fabio Conti, Matteo Tonnini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Francesco Giuseppe Foschi, Piscaglia Fabio, Alessandro Granito, Francesco Tovoli
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy. Current oncology (Toronto, Ont.) 31 (1) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Bernardo Stefanini, Luca Ielasi, Rusi Chen, Chiara Abbati, Matteo Tonnini, Francesco Tovoli, Alessandro Granito
TKIs in combination with immunotherapy for hepatocellular carcinoma. Expert review of anticancer therapy 23 (3) (2023)
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, Francesco Tovoli, Piscaglia Fabio, Rita Golfieri, Matteo Renzulli
COVID-19: Has the Liver Been Spared? International journal of molecular sciences 24 (2) (2023)
Ingrid Garajovà, Fabio Gelsomino, Massimiliano Salati, Francesco Leonardi, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis. Current oncology (Toronto, Ont.) 30 (3) (2023)
Bernardo Stefanini, Luca Ielasi, Rusi Chen, Chiara Abbati, Matteo Tonnini, Francesco Tovoli, Alessandro Granito
TKIs in combination with immunotherapy for hepatocellular carcinoma. Expert review of anticancer therapy (2023)
Catia Giovannini, Fabrizia Suzzi, Francesco Tovoli, Mariangela Bruccoleri, Mariarosaria Marseglia, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, Piscaglia Fabio, Laura Gramantieri
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma. Cancers 15 (6) (2023)
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, Francesco Tovoli, Piscaglia Fabio, Rita Golfieri, Matteo Renzulli
COVID-19: Has the Liver Been Spared? International journal of molecular sciences 24 (2) (2023)
Ingrid Garajovà, Fabio Gelsomino, Massimiliano Salati, Francesco Leonardi, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis. Current oncology (Toronto, Ont.) 30 (3) (2023)
Ingrid Garajovà, Fabio Gelsomino, Massimiliano Salati, Francesco Leonardi, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli
Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis. Current oncology (Toronto, Ont.) 30 (3) (2023)
Francesco Tovoli, Dante Pio Pallotta, Alice Giamperoli, Guido Zavatta, Kinga Skoracka, Alberto Raiteri, Chiara Faggiano, Iwona Krela-Kaźmierczak, Alessandro Granito
Evolution of bone densitometry parameters and risk of fracture in coeliac disease: a 10-year perspective. Internal and emergency medicine (2023)
Luca Ielasi, Francesco Tovoli, Matteo Tonnini, Bernardo Stefanini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Ingrid Garajovà, Piscaglia Fabio, Alessandro Granito
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma. Cancers 15 (5) (2023)
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, Francesco Tovoli, Piscaglia Fabio, Rita Golfieri, Matteo Renzulli
COVID-19: Has the Liver Been Spared? International journal of molecular sciences 24 (2) (2023)
Bernardo Stefanini, Luca Ielasi, Rusi Chen, Chiara Abbati, Matteo Tonnini, Francesco Tovoli, Alessandro Granito
TKIs in combination with immunotherapy for hepatocellular carcinoma. Expert review of anticancer therapy (2023)
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, Francesco Tovoli, Piscaglia Fabio, Rita Golfieri, Matteo Renzulli
COVID-19: Has the Liver Been Spared? International journal of molecular sciences 24 (2) (2023)
Luca Ielasi, Francesco Tovoli, Matteo Tonnini, Bernardo Stefanini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Ingrid Garajovà, Piscaglia Fabio, Alessandro Granito
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma. Cancers 15 (5) (2023)
Bernardo Stefanini, Luca Ielasi, Rusi Chen, Chiara Abbati, Matteo Tonnini, Francesco Tovoli, Alessandro Granito
TKIs in combination with immunotherapy for hepatocellular carcinoma. Expert review of anticancer therapy 23 (3) (2023)
Catia Giovannini, Fabrizia Suzzi, Francesco Tovoli, Mariangela Bruccoleri, Mariarosaria Marseglia, Eleonora Alimenti, Francesca Fornari, Massimo Iavarone, Piscaglia Fabio, Laura Gramantieri
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab-Bevacizumab in Hepatocellular Carcinoma. Cancers 15 (6) (2023)
Kinga Skoracka, Szymon Tytus Hryhorowicz, Francesco Tovoli, Alberto Raiteri, Anna Maria Rychter, Ryszard Slomski, Agnieszka Dobrowolska, Alessandro Granito, Iwona Krela-Kaźmierczak
Genetic, Immunological, Dietary, Gut Microbiota, and Environmental Determinants of Osteoporosis in the Course of Celiac Disease: Which Factor Plays the First Violin in This Orchestra? Calcified tissue international (2023)
Bernardo Stefanini, Luca Ielasi, Rusi Chen, Chiara Abbati, Matteo Tonnini, Francesco Tovoli, Alessandro Granito
TKIs in combination with immunotherapy for hepatocellular carcinoma. Expert review of anticancer therapy 23 (3) (2023)
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, Francesco Tovoli, Piscaglia Fabio, Rita Golfieri, Matteo Renzulli
COVID-19: Has the Liver Been Spared? International journal of molecular sciences 24 (2) (2023)
Ingrid Garajovà, Fabio Gelsomino, Massimiliano Salati, Anna Mingozzi, Marianna Peroni, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli, Francesco Leonardi
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? Life (Basel, Switzerland) 13 (11) (2023)
Eleonora Terzi, Alice Giamperoli, Massimo Iavarone, Simona Leoni, Ludovico De Bonis, Alessandro Granito, Antonella Forgione, Francesco Tovoli, Piscaglia Fabio
Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5). Cancers 14 (2) (2022)
Alberto Raiteri, Alessandro Granito, Chiara Faggiano, Alice Giamperoli, Teresa Catenaro, Giulia Negrini, Francesco Tovoli
Hepatic Steatosis in Patients with Celiac Disease: The Role of Packaged Gluten-Free Foods. Nutrients 14 (14) (2022)
Laura Gramantieri, Federica Gnudi, Francesco Vasuri, Daniele Mandrioli, Francesca Fornari, Francesco Tovoli, Fabrizia Suzzi, Andrea Vornoli, Antonia D'Errico, Piscaglia Fabio, Catia Giovannini
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area. Nutrients 14 (8) (2022)
Matteo Renzulli, Nicolò Brandi, Anna Pecorelli, Luigi Vincenzo Pastore, Alessandro Granito, Giuseppe Martinese, Francesco Tovoli, Mario Simonetti, Elton Dajti, Antonio Colecchia, Rita Golfieri
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Matteo Renzulli, Anna Pecorelli, Nicolò Brandi, Stefano Brocchi, Francesco Tovoli, Alessandro Granito, Gianpaolo Carrafiello, Anna Maria Ierardi, Rita Golfieri
The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool? Journal of clinical medicine 11 (15) (2022)
Andrea Vornoli, Eva Tibaldi, Federica Gnudi, Daria Sgargi, Fabiana Manservisi, Fiorella Belpoggi, Francesco Tovoli, Daniele Mandrioli
Evaluation of Toxicant-Associated Fatty Liver Disease and Liver Neoplastic Progress in Sprague-Dawley Rats Treated with Low Doses of Aflatoxin B1 Alone or in Combination with Extremely Low Frequency Electromagnetic Fields. Toxins 14 (5) (2022)
Piera Federico, Emilio Francesco Giunta, Andrea Tufo, Francesco Tovoli, Angelica Petrillo, Bruno Daniele
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact. Cancers 14 (24) (2022)
Stefania De Lorenzo, Francesco Tovoli, Franco Trevisani
Mechanisms of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma. Cancers 14 (19) (2022)
Silvia Ferri, Bernardo Stefanini, Lorenzo Mulazzani, Margherita Alvisi, Francesco Tovoli, Simona Leoni, Luca Muratori, Tommaso Lotti, Alessandro Granito, Luigi Bolondi, Piscaglia Fabio
Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients 14 (12) (2022)
Piera Federico, Emilio Francesco Giunta, Andrea Tufo, Francesco Tovoli, Angelica Petrillo, Bruno Daniele
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact. Cancers 14 (24) (2022)
Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli
Surveillance for hepatocellular carcinoma: current status and future perspectives for improvement. Expert review of anticancer therapy 22 (4) (2022)
Francesco Tovoli, Chiara Faggiano, Alberto Raiteri, Alice Giamperoli, Teresa Catenaro, Vito Sansone, Dante Pio Pallotta, Alessandro Granito
Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients? Nutrients 14 (6) (2022)
Bernardo Stefanini, Matteo Tonnini, Mariarosaria Marseglia, Francesco Tovoli
Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis? Expert review of anticancer therapy 22 (9) (2022)
Alberto Raiteri, Margherita Alvisi, Ilaria Serio, Federico Stefanini, Francesco Tovoli, Fabio Piscaglia
Lung Ultrasound Is Often, but Not Always, Normal in Healthy Subjects: Considerations for COVID-19 Pandemic. Diagnostics (Basel, Switzerland) 11 (1) (2021)
Stefania De Lorenzo, Ingrid Garajovà, Bernardo Stefanini, Francesco Tovoli
Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development. Expert opinion on investigational drugs 30 (7) (2021)
Alessandro Granito, Antonio Facciorusso, Rodolfo Sacco, Laura Bartalena, Cristina Mosconi, Ugo Vittorio Cea, Alberta Cappelli, Matteo Antonino, Francesco Modestino, Nicolò Brandi, Francesco Tovoli, Piscaglia Fabio, Rita Golfieri, Matteo Renzulli
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma. Journal of personalized medicine 11 (10) (2021)
Francesco Tovoli, Ingrid Garajovà, Fabio Gelsomino, Massimo Iavarone, Piera Federico, Massimiliano Salati, Matilde Corianò, Raffaella D'Onofrio, Stefania De Lorenzo, Alessandro Granito, Matteo Renzulli, Bruno Daniele, Piscaglia Fabio
Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second-line clinical trials. Liver international : official journal of the International Association for the Study of the Liver (2021)
Luca Ielasi, Francesco Tovoli, Matteo Tonnini, Raffaella Tortora, Giulia Magini, Rodolfo Sacco, Tiziana Pressiani, Franco Trevisani, Vito Sansone, Giovanni Marasco, Piscaglia Fabio, Alessandro Granito
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders. Cancers 13 (24) (2021)
Francesco Tovoli, Stefania De Lorenzo, Franco Trevisani
Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now? Vaccines 8 (4) (2020)
Simona Leoni, Vito Sansone, Stefania De Lorenzo, Luca Ielasi, Francesco Tovoli, Matteo Renzulli, Rita Golfieri, Daniele Spinelli, Fabio Piscaglia
Treatment of Combined Hepatocellular and Cholangiocarcinoma. Cancers 12 (4) (2020)
Stefania De Lorenzo, Francesco Tovoli, Alessandro D Mazzotta, Francesco Vasuri, Julien Edeline, Deborah Malvi, Karim Boudjema, Matteo Renzulli, Heithem Jeddou, Antonietta D'Errico, Bruno Turlin, Matteo Cescon, Thomas Uguen, Alessandro Granito, Astrid Lièvre, Giovanni Brandi
Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role. Cancers 12 (11) (2020)
Elisabetta Goio, Luca Ielasi, Francesca Benevento, Matteo Renzulli, Francesco Tovoli
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery. Hepatic oncology 7 (3) (2020)
Elisabetta Sagrini, Massimo Iavarone, Federico Stefanini, Francesco Tovoli, Sara Vavassori, Marco Maggioni, Matteo Renzulli, Veronica Salvatore, Horia Stefanescu, Massimo Colombo, Luigi Bolondi, Piscaglia Fabio
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma. United European gastroenterology journal 7 (1) (2018)
Francesco Tovoli, Matteo Renzulli, Giulia Negrini, Stefano Brocchi, Alessia Ferrarini, Andrea Andreone, Francesca Benevento, Rita Golfieri, Antonio Maria Morselli-Labate, Marianna Mastroroberto, Radu Ion Badea, Fabio Piscaglia
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib. European radiology 28 (9) (2018)
Francesco Tovoli, G Negrini, R Farì, E Guidetti, C Faggiano, L Napoli, Luigi Bolondi, Alessandro Granito
Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors. Alimentary pharmacology & therapeutics 48 (5) (2018)
Francesco Tovoli, Giulia Negrini, Vito Sansone, Chiara Faggiano, Teresa Catenaro, Luigi Bolondi, Alessandro Granito
Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis. Nutrients 10 (12) (2018)
Filomena Morisco, Maria Guarino, Maria R Valvano, Francesco Auriemma, Fabio Farinati, Edoardo G Giannini, Francesca Ciccarese, Francesco Tovoli, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Giuseppe Cabibbo, Martina Felder, Luisa Benvengù, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco G Foschi, Elisabetta Biasini, Alberto Masotto, Roberto Virdone, Fabio Marra, Nicola Caporaso, Franco Trevisani, null null
Metabolic disorders across hepatocellular carcinoma in Italy. Liver international : official journal of the International Association for the Study of the Liver 38 (11) (2018)
Francesco Tovoli, Stefania De Lorenzo, Boaz Gedaliahu Samolsky Dekel, Piscaglia Fabio, Francesca Benevento, Giovanni Brandi, Luigi Bolondi
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 38 (2) (2017)

Francesco Tovoli.css-eqlu8i{font-size:small;padding-left:4px;} (F Tovoli)

Publication Activity (10 Years)

Top Topics

Top Venues

Francesco Tovoli (F Tovoli)